SkinBioTherapeutics

SkinBioTherapeutics is a biotechnology company developing microbiome-based technologies for skin health.

Its proprietary platform harnesses lysates derived from probiotic bacteria to improve skin barrier function, reduce infection risk, and support wound healing.

Programmes target cosmetic skincare, psoriasis, eczema, and infection control markets, with a commercial partnership with Croda International for cosmetic ingredient development.

The food supplement for psoriasis is commercially available across multiple markets.